TABLE 2.

PCR for C. pneumoniae in the CSF of patients with clinically definite MS

Patient	Diagnosisa	Age (yr)	Gender	CSF characteristics			IgG indexb	OCc bands	PCR assay results
									VUMCd		USF with MOMP primere
				Cell count (no. of cells/μl)	Protein concn (mg/dl)	Glucose concn (mg/dl)			VU-MOMP	Tong and Sillis
1	Sec MS	45	F	NDf	ND	ND	ND	ND	+	+	+
2	RR MS	47	M	4	44	58	1.2	+	+	−	+
3	RR MS	26	F	ND	ND	ND	ND	ND	+	+	+
4	RR MS	40	M	1	34	68	0.6	−	+	+	+
5	RR MS	51	M	4	62	54	1.27	+	+	+	+
6	RR MS	59	F	2	51	60	0.6	+	−	−	+
7	RR MS	48	F	2	48	59	0.7	+	+	−	+
8	Sec MS	58	M	2	67	100	1.09	−	+	+	+
9	Sec MS	44	F	1	66	63	1.15	+	+	+	+
10	Sec MS	55	M	0	35	69	0.75	+	−	−	−
11	Sec MS	42	F	1	31	54	0.84	+	−	+	−
12	RR MS	55	F	1	28	48	0.73	+	−	−	−
13	RR MS	55	F	2	37	57	0.49	−	+	+	−
14	Sec MS	61	F	ND	ND	ND	ND	ND	+	+	−
15	Sec MS	66	F	1	64	61	0.58	−	+	+	−
16	RR MS	32	F	5	17	61	0.72	−	−	−	−
17	Sec MS	57	M	4	82	64	0.57	+	+	+	+
18	RR MS	62	M	3	43	55	0.07	+	+	+	+

^aAbbreviations: Sec MS, secondary progressive MS; RR MS, relapsing remitting MS.

^bIgG, immunoglobulin G.

^cOC, oligoclonal.

^dThe total numbers of samples positive were 13 and 12 for the Vu-MOMP and Tong and Sillis primers, respectively.

^eThe total number of samples positive was 11.

^fND, not done.